SHORT VERSION
A follow-up at 6 months from the end of the treatments and then an annual follow-up alternating between the surgeon, the radiotherapy oncologist, possibly the medical oncologist and the general practitioner will be set up. This monitoring will take place over several years and aims to :
- to assess the tolerance of the treatment and in particular to monitor the possible appearance of late complications
- look for a possible tumour recurrence.
Follow-up after the end of the breast cancer treatment sequence is alternated between the surgeon, the radiation oncologist, possibly the medical oncologist and the general practitioner.
After radiotherapy, the aim of follow-up is twofold. First of all, it is aboutassess the tolerance of the treatmentThe aim of the study was to investigate the occurrence of late side effects related to the locoregional treatment (surgery + radiotherapy). It is also about Search forarguments for tumour recurrence in the breast or in the contralateral breast. For this purpose, a first senological surveillance is carried out at 6 months after the end of radiotherapy by clinical examination (palpation of the breast and lymph nodes) and by breast ultrasound, mammography +/- breast MRI in certain indications. TheClinical examination will be repeated every 6 months during a consultation with one of the doctors (surgeon or oncologist). Imaging will be repeated on an annual basis. This follow-up will also make it possible to observe the appearance of late complications.
Biological monitoring by blood sampling may be carried out as part of the monitoring of the tolerance of hormone therapy if such treatment has been indicated, as well as monitoring of bone densitometry.
